Barely Significant
← all excerpts

Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer.

Eur J Nucl Med Mol Imaging · 2026 · PMC12920758 · PMID 41174098

Europe PMCDOI
1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

failed to reach significanceP = 0.057so close (0.05 < p ≤ 0.1)
PSMA-TV ( P = 0.036) and TL-PSMA ( P = 0.041) also emerged as significant predictors, while SUV max failed to reach significance ( P = 0.057).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.